NCT07079592 A Deep-Learning-Enabled Electrocardiogram for Detecting Pulmonary Hypertension
| NCT ID | NCT07079592 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Defense Medical Center, Taiwan |
| Condition | Artificial Intelligence (AI) |
| Study Type | INTERVENTIONAL |
| Enrollment | 8,666 participants |
| Start Date | 2026-02 |
| Primary Completion | 2026-06-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 8,666 participants in total. It began in 2026-02 with a primary completion date of 2026-06-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to validate the use of an artificial intelligence-enabled electrocardiogram (AI-ECG) to screen for elevated PAP. We hypothesize that the AI-ECG model can early identify patients with pulmonary hypertension in high-risk patients, prompting further evaluation through echocardiography, potentially resulting in improving cardiovascular outcomes.
Eligibility Criteria
Inclusion Criteria: * Men or women, ≥ 50 to 85 years of age * At least one 12-lead ECG within 3 months Exclusion Criteria: * A diagnosis of PH WHO Groups 1, 2, 3, 4, or 5 * A diagnosis of hypertrophic cardiomyopathy, restrictive cardiomyopathy, constrictive pericarditis, cardiac amyloidosis, or infiltrative cardiomyopathy * Prior heart, lung, or heart-lung transplants * Any systolic pulmonary artery pressure \>50 mmHg by echocardiography before * Echocardiography in 3 months before index ECG
Contact & Investigator
Chin Lin, associate professor
STUDY DIRECTOR
National Defense Medical Center, Taiwan
Frequently Asked Questions
Who can join the NCT07079592 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 85 Years, studying Artificial Intelligence (AI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07079592 currently recruiting?
Yes, NCT07079592 is actively recruiting participants. Contact the research team at up6fup0629@gmail.com for enrollment information.
Where is the NCT07079592 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT07079592 clinical trial?
NCT07079592 is sponsored by National Defense Medical Center, Taiwan. The principal investigator is Chin Lin, associate professor at National Defense Medical Center, Taiwan. The trial plans to enroll 8,666 participants.